Details werden geladen...
FDA approves new pancreatic cancer drug after trial doubles patient survival | Israel National News
The FDA approves Revolution Medicines’ Rasonque for metastatic pancreatic cancer after a trial showed the drug doubled survival for patients.
Ähnliche Seiten
New hope for pancreatic cancer patients after FDA approves drug shown to improve survival | The Independent
https://www.independent.co.uk/news/health/pancreatic-cancer-drug-treatment-daraxonrasib-fda-b3039868.html
FDA approves landmark pancreatic cancer drug that's shown to improve survival | The Manila Times
https://www.manilatimes.net/2026/08/27/world/fda-approves-landmark-pancreatic-cancer-drug-thats-shown-to-improve-survival/2413092
Breakthrough drug nearly doubles survival rate for advanced pancreatic cancer
https://refractor.io/cancer/breakthrough-drug-doubles-survival-pancreatic-cancer/
FDA Approves Landmark Pancreatic Cancer Drug That's Shown To Improve Survival | HuffPost Latest News
https://www.huffpost.com/entry/pancreatic-cancer-drug-fda_n_6a8f4065e4b0a9d5e57c8bf8FDA approves landmark pancreatic cancer drug that's shown to improve survival | The Independent
https://www.independent.co.uk/news/patients-fda-washington-american-cancer-society-cbs-b3039814.html